The Hepatitis C Transplant Collaborative

Recruiting Observational Study
Transplant; Failure, Heart Hepatitis C
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Baylor Research Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Recipient of a proven HCV NAT+ donor heart. 2. Re-transplant patients will be included. Exclusion Criteria: 1\. Multi-organ transplantation
Contacts

Joost Felius, PhD

214-818-8943

Joost.Felius@BSWHEALTH.ORG

CONTACT